EpiCept Corporation (EPCT) Reports First Quarter 2013 Operating and Financial Results  
5/20/2013 9:59:05 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced operating and financial results for the three months ended March 31, 2013, and provided an update on the Company’s planned merger with Immune Pharmaceuticals, Ltd. (Immune).

Help employers find you! Check out all the jobs and post your resume.